B7-H7 Is Inducible on T Cells to Regulate Their Immune Response and Serves as a Marker for Exhaustion

Front Immunol. 2021 Jun 1:12:682627. doi: 10.3389/fimmu.2021.682627. eCollection 2021.

Abstract

The discovery of immune checkpoints highlights the complexity of T cell signalling during an immune response. Upon activation, T cells express several molecules to regulate their function and to prevent overactivation. B7 homolog 7 (B7-H7) is expressed in tumours and associated with a worse prognosis. However, conflicting data regarding its function suggest that it can be both stimulatory and inhibitory. In this study we report that B7-H7 is also expressed on T cells upon cross-linking of CD3 and CD28 and that additional stimulation via CD137 further enhances the expression of B7-H7. B7-H7 is preferentially expressed on exhausted Th1 and Tc1 cells with an impaired secretion of TNF-α and IFN-γ. Blockade of B7-H7 with its natural receptor, recombinant CD28H, enhances T cell proliferation and activation. Thus, B7-H7 represents another target for immunotherapy and a biomarker to select for active effector T cells with relevance for adoptive cell transfer therapy.

Keywords: T lymphocyte; exhaustion; immune checkpoint; immunology; immunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B7 Antigens / genetics
  • B7 Antigens / immunology*
  • Biomarkers
  • Gene Expression Profiling
  • Humans
  • Immunomodulation / drug effects
  • Immunophenotyping
  • Lymphocyte Activation / genetics
  • Lymphocyte Activation / immunology*
  • Lymphocyte Culture Test, Mixed
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism*
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • B7 Antigens
  • Biomarkers
  • TOR Serine-Threonine Kinases